News + Filings Transactions
|
MCGUIRE TERRANCE
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/22/2023 | Alector, Inc. | ALEC | Other (acquisition) | Common Stock | 13.1k | $0.00 | $0 | See footnote | 08/22/2023 |
| 08/22/2023 | Alector, Inc. | ALEC | Other (disposition) | Common Stock | 98.5k | $0.00 | $0 | See footnote | 08/22/2023 |
| 08/22/2023 | Alector, Inc. | ALEC | Other (acquisition) | Common Stock | 98.5k | $0.00 | $0 | See footnote | 08/22/2023 |
| 08/22/2023 | Alector, Inc. | ALEC | Other (acquisition) | Common Stock | 6.4k | $0.00 | $0 | | 08/22/2023 |
| 08/22/2023 | Alector, Inc. | ALEC | Other (disposition) | Common Stock | 500k | $0.00 | $0 | See footnote | 08/22/2023 |
| 08/09/2023 | Cyclerion Therapeutics, Inc. | CYCN | Sale | Common Stock | 8 | $3.40 | $27.2 | By Polaris Venture Management Co. II, L.L.C. | 08/09/2023 |
| 06/14/2023 | Seer, Inc. | SEER | Grant | Class A Common Stock | 23.4k | $0.00 | $0 | | 06/14/2023 |
| 06/14/2023 | Seer, Inc. | SEER | Grant | Stock Option (right to buy) | 34.7k | $4.33 | $150.4k | | 06/14/2023 |
| 05/23/2023 | Invivyd, Inc. | | Grant | Stock Option (Right to Buy) | 50k | $1.70 | $85k | | 05/23/2023 |
| 11/16/2022 | Alector, Inc. | ALEC | Other (disposition) | Common Stock | 500k | $0.00 | $0 | See footnote | 11/16/2022 |
| 11/16/2022 | Alector, Inc. | ALEC | Other (acquisition) | Common Stock | 13.1k | $0.00 | $0 | See footnote | 11/16/2022 |
| 11/16/2022 | Alector, Inc. | ALEC | Other (acquisition) | Common Stock | 6.4k | $0.00 | $0 | | 11/16/2022 |
| 11/16/2022 | Alector, Inc. | ALEC | Other (acquisition) | Common Stock | 98.5k | $0.00 | $0 | See footnote | 11/16/2022 |
| 11/16/2022 | Alector, Inc. | ALEC | Other (disposition) | Common Stock | 98.5k | $0.00 | $0 | See footnote | 11/16/2022 |
| 06/22/2022 | Invivyd, Inc. | | Grant | Stock Option (Right to Buy) | 75k | $3.09 | $231.8k | | 06/22/2022 |
| 06/16/2022 | Alector, Inc. | ALEC | Grant | Common Stock | 9.5k | $0.00 | $0 | | 06/16/2022 |
| 06/16/2022 | Alector, Inc. | ALEC | Grant | Stock Option (right to buy) | 18.9k | $8.07 | $152.7k | | 06/16/2022 |
| 06/15/2022 | Seer, Inc. | SEER | Grant | Class A Common Stock | 9.9k | $0.00 | $0 | | 06/15/2022 |
| 06/15/2022 | Seer, Inc. | SEER | Grant | Stock Option (right to buy) | 29.6k | $7.33 | $217.3k | | 06/15/2022 |
| 06/14/2022 | Cyclerion Therapeutics, Inc. | CYCN | Grant | Stock Option (Right to Buy) | 20k | $0.53 | $10.6k | | 06/14/2022 |
| 12/21/2021 | Alector, Inc. | ALEC | Other (disposition) | Common Stock | 500k | $0.00 | $0 | See footnote | 12/21/2021 |
| 12/21/2021 | Alector, Inc. | ALEC | Other (acquisition) | Common Stock | 6.4k | $0.00 | $0 | | 12/21/2021 |
| 12/21/2021 | Alector, Inc. | ALEC | Other (acquisition) | Common Stock | 98.5k | $0.00 | $0 | See footnote | 12/21/2021 |
| 12/21/2021 | Alector, Inc. | ALEC | Other (disposition) | Common Stock | 98.5k | $0.00 | $0 | See footnote | 12/21/2021 |
| 12/21/2021 | Alector, Inc. | ALEC | Other (acquisition) | Common Stock | 13.1k | $0.00 | $0 | See footnote | 12/21/2021 |
| 08/10/2021 | Invivyd, Inc. | | Purchase | Common Stock | 177.5k | $17.00 | $3M | See Footnote | 08/10/2021 |
| 08/10/2021 | Invivyd, Inc. | | Conversion | Series A Preferred Stock | 361.8k | $0.00 | $0 | See Footnote | 08/10/2021 |
| 08/10/2021 | Invivyd, Inc. | | Conversion | Series A Preferred Stock | 7.1k | $0.00 | $0 | See Footnote | 08/10/2021 |
| 08/10/2021 | Invivyd, Inc. | | Conversion | Series A Preferred Stock | 2.5k | $0.00 | $0 | See Footnote | 08/10/2021 |
| 08/10/2021 | Invivyd, Inc. | | Conversion | Series A Preferred Stock | 3.6k | $0.00 | $0 | See Footnote | 08/10/2021 |
| 08/10/2021 | Invivyd, Inc. | | Conversion | Series A Preferred Stock | 875k | $0.00 | $0 | See Footnote | 08/10/2021 |
| 08/10/2021 | Invivyd, Inc. | | Conversion | Series B Preferred Stock | 85.1k | $0.00 | $0 | See Footnote | 08/10/2021 |
| 08/10/2021 | Invivyd, Inc. | | Conversion | Series B Preferred Stock | 1.7k | $0.00 | $0 | See Footnote | 08/10/2021 |
| 08/10/2021 | Invivyd, Inc. | | Conversion | Series B Preferred Stock | 583 | $0.00 | $0 | See Footnote | 08/10/2021 |
| 08/10/2021 | Invivyd, Inc. | | Conversion | Series B Preferred Stock | 850 | $0.00 | $0 | See Footnote | 08/10/2021 |
|
|